"You obviously don't know it but you're whole basis of fact is relying on what management says. ABT is only making a study to see if the technology works and they don't know yet after all this time."
Reverse you don't know what you are talking about. Common sense should tell you that Abbott has already confirmed the tech works. They are working toward integrating it into their architect system, then towards FDA approval for their system. You're saying that a company as large, dominant in the field of cancer diagnostics, with the resources and know how as Abbott, after more than a year and a half of working and learning the ins and outs of recaf, along with the option of returning the licensing agreement at any time, does not know whether or not the technology works! SHUT UP!!! You deserved to be slapped, or be wearing a dunce cap, as Bocxman would say!
News 
Market Data 
Discover 
